Phase-3 trial of Bharat Biotechs Covaxin commences in AIIMS
The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS here on Thursday with Dr M V Padma...
ABU Dhabi launches Hope Consortium for global vaccine distribution
Amid an anticipated surge in vaccine logistics demand, Abu Dhabi is poised to cement its position as the global logistics hub to facilitate COVID-19...
China likely to approve a COVID-19 vaccine by year end to meet the need of epidemic-stricken countries
As Brazilian health officials expressed hope for China to hasten approval process for a China developed vaccine and more countries are laying out vaccination...
FDA authorizes monoclonal antibodies for treatment of COVID-19
FDA issued an EUA for casirivimab and imdevimab (Regeneron Pharmaceuticals) to be administered together for the treatment of mild to moderate COVID-19 in adults...
AstraZeneca says AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in...
Lilly’s neutralizing antibody bamlanivimab receives interim authorization from Health Canada as a treatment for COVID-19
Health Canada granted authorization under the Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 for the...
Catalent Signs Commercial Supply Agreement with Blueprint Medicines Following FDA Approval of GAVRETO
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...